Name: WSJ News Exclusive | If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could Profit
Brand: wsj.com
SKU: wsj-com-347
Availability: OnlineOnly

critic

WSJ News Exclusive | If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could Profit

preview

Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/if-oxfords-covid-19-vaccine-succeeds-layers-of-private-investors-could-profit-11596373722ShareBy Aug. 2, 2020 9:08 am ETIn the race for a Covid-19 vaccine, the University of Oxford stands out. The 900-year-old school’s Jenner Institute is competing against a number of large, publicly traded pharmaceutical companies whose investors could gain handsomely from an effective jab.Even at Oxford, though, layers of private investors are poised behind the scenes to profit if the vaccine works. They include the university itself, two of the scientists at the center of the program’s research and a little-known investment firm started last year by a former Deutsche Bank equities trader.Continue reading your article witha WSJ membershipAlready a member? Sponsored OffersCopyright ©2022 Dow Jones &amp; Company, Inc. All Rights ReservedThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Skip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.https://www.wsj.com/articles/if-oxfords-covid-19-vaccine-succeeds-layers-of-private-investors-could-profit-11596373722ShareBy Aug. 2, 2020 9:08 am ETIn the race for a Covid-19 vaccine, the University of Oxford stands out. The 900-year-old school’s Jenner Institute is competing against a...

public

Jenny Strasburg

Sign up for our newsletters and email alerts: http://wsj.com/newsletters

wsj.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

WSJ News Exclusive | If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could Profit

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS